Magda Szubanski is feeling the love from her famous pals and longtime fans as she battles cancer. The Australian comedian announced in May that she's battling Mantle Cell Lymphoma - a rare and ...

Magda Szubanski has provided fans with a heartfelt and surprisingly upbeat update as she battles stage four cancer.

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates (ADCs)—in a Lunsumio-Polivy regimen in large B-cell lymphoma (LBCL ...

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma (LBCL) who have different ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) occurring in patients with advanced B-cell lymphoma (BCL). The the ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma.

Mantle cell lymphoma (MCL) represents a relatively uncommon, heterogeneous lymphoma associated with limited overall survival. Targeting of the B-cell receptor pathway in relapsed disease with covalent ...

Sebastião Salgado: A Life in Pictures The celebrated Brazilian photojournalist depicted the world in stark contrasts, from the depths of human suffering to the monumental grandeur of nature.

Breyanzi was approved in 2024 to treat a type of non-Hodgkin lymphoma called large B-cell lymphoma (LBCL). Below you’ll find common questions and answers about Breyanzi to help decide whether it ...

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients with relapsed or refractory mantle cell lymphoma in a phase 1/2 study.In ...